ABIOMED Dividenda 2024

Detalji o dividendama

Razumevanje dividendnih isplata od ABIOMED

Dividende od ABIOMED su deo profita kompanije koji se distribuira akcionarima. One su ključni indikator finansijskog zdravlja kompanije i atraktivnosti za investitore. Dividende pružaju investitorima stabilan izvor prihoda, pored dobiti koja se možda može ostvariti prodajom akcija po višoj ceni od kupovne.

Poređenje iz godine u godinu

Analiza isplata dividendi od ABIOMED tokom godina može istaći profitabilnost i stabilnost kompanije. Konstantno ili rastuće isplate dividendi mogu ukazivati na finansijski zdravu kompaniju sa predvidivim profitom, dok fluktuacije ili smanjenja dividendi mogu signalizirati osnovne finansijske ili operativne izazove.

Uticaj na investicije

Isplate dividendi od ABIOMED su suštinski faktor za investitore orijentisane na prihod. Robusna isplata dividendi može povećati privlačnost akcije i pružiti redovni prihod pored potencijalnih kapitalnih dobitaka. Ona može takođe pokazati poverenje kompanije u njene buduće profite i time biti značajan faktor za odlučivanje o investicijama.

Interpretacija fluktuacija dividendi

Promene u dividendama od ABIOMED mogu proistići iz promena u profitima kompanije, finansijskoj politici ili strategijama reinvestiranja. Povećanje dividendi često signalizira finansijsku stabilnost, dok smanjenje može ukazivati na potrebu da se sačuva gotovina ili da se profiti reinvestiraju radi podsticanja rasta, pri čemu svaki scenario ima različite posledice za investitore.

ABIOMED Aktienanalyse

Шта ради ABIOMED?

Abiomed Inc. is one of the most innovative companies in the medical technology industry. It was founded in 1981 and is headquartered in Danvers, Massachusetts. The company specializes in the development, manufacturing, and marketing of medical devices aimed at saving or improving patients' lives. Abiomed started as a small company focused on implantation technology for cardiac arrhythmias. However, the company soon recognized the need to concentrate on providing solutions for cardiac intensive care. Today, Abiomed is a leader in the field of cardiopulmonary support systems and offers innovative devices to support the heart. Abiomed's business model revolves around leveraging its expertise in medical technology for cardiology interventions and intensive care and bringing innovative products to market. The company has industry experts and doctors on its team who contribute to the development and manufacturing of products. This highest level of professionalism is also reflected in the distribution channels Abiomed utilizes, with a focus on delivering its products to clinics specialized in critical medical interventions. Abiomed is divided into various business segments that concentrate on the medical devices the company offers. One of these segments is the Impella portfolio, which focuses on heart pumps for acute heart failure. These pumps are capable of supporting the heart during cardiological intervention by pumping blood into the heart while artificially ventilating it. The Impella portfolio is recognized as a standard in cardiac intensive care. Another important area for Abiomed is product development. The company heavily invests in researching and developing new products to meet the current demand in cardiology on the market. Abiomed is aware that rapid development of new products can provide a competitive advantage and, therefore, is an essential part of its business model. The technology offered by Abiomed is revolutionary and allows for the treatment of patients with acute heart failure, which was previously difficult or impossible. This is a significant milestone for the company and the healthcare industry in general. Abiomed is aware of its responsibility towards patients, doctors, and hospitals and is continuously working to develop innovative solutions for the healthcare industry. In summary, Abiomed Inc. is a leading company in the medical technology industry that focuses on cardiology intervention and intensive care. The company is innovative and offers products that can save and improve patients' lives. The Impella portfolio, specializing in acute heart failure, is an important part of its business model. Abiomed heavily invests in research and development to consistently provide innovative solutions to its customers. ABIOMED je jedna od najpopularnijih kompanija na Eulerpool.com.

Često postavljana pitanja o ABIOMED akciji

Kolika je dividenda koju isplaćuje ABIOMED?

U poslednjih 12 meseci, ABIOMED je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, ABIOMED će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za ABIOMED?

Dividendski prinos od ABIOMED trenutno iznosi .

Kada ABIOMED isplaćuje dividendu?

ABIOMED isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od ABIOMED?

ABIOMED je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije ABIOMED?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi ABIOMED?

ABIOMED se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von ABIOMED kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od ABIOMED od 19. 5. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 19. 5. 2024..

Kada je ABIOMED poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 19. 5. 2024..

Kolika je bila dividenda od ABIOMED u godini 2023?

U godini 2023 kompanija ABIOMED je isplatila 0 USD kao dividende.

U kojoj valuti ABIOMED isplaćuje dividendu?

Dividende od ABIOMED se isplaćuju u USD.